GOLDMAN SACHS GROUP$97.04
+0.18
| Last Trade: |
97.04 |
| Trade Time: |
May 25 2:04 PM Eastern Daylight Time |
| Change: |
0.18 (0.19 %) |
| Prev Close: |
96.86 |
| Open: |
96.54 |
| Bid: |
97.04 |
| Ask: |
97.06 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
1/25/2012
|
BLANKFEIN LLOYD C
|
Chairman of the Board and CEO
|
-21,248
|
$107.44
|
-1.16%
|
|
1/25/2012
|
WEINBERG JOHN S
|
Vice Chairman
|
-19,314
|
$107.44
|
-2.65%
|
|
1/25/2012
|
VINIAR DAVID A
|
Executive Vice President - CFO
|
-21,248
|
$107.44
|
-2.53%
|
|
1/25/2012
|
SMITH SARAH G
|
Principal Accounting Officer
|
-11,323
|
$107.44
|
-26.98%
|
|
1/25/2012
|
SHERWOOD MICHAEL S
|
Vice Chairman
|
-11,605
|
$107.44
|
-8.99%
|
-
In the first quarter, things were finally groovy for major bank stocks and the corresponding ETFs. Bank of America (NYSE: BAC) jumped about 70% and was the best-performing stock in the Dow Jones Indu ...
Read More »
-
Facebook (NASDAQ: FB), the largest social media company, is now two days into life as a public company and things aren't looking good. That's not to say most anticipated IPO in nearly a decade won't ...
Read More »
-
From the moment U.S. markets opened on Friday, it was an ominous start as a public company for social media darling Facebook (NASDAQ: FB). In what was the most anticipated technology sector IPO since ...
Read More »
-
It was revealed on Thursday that Human Genome Sciences (NASDAQ: HGSI) is in talks with, in its own words "major" pharmaceutical and biotechnology companies in a bid to do whatever it can to avoid a ho ...
Read More »
-
An opportunity to buy these banks when prices fall from current levels is likely to reward investors with a long-term holding period.
Read More »
-
As global growth has begun to slow, the prices for various commodities have dwindled as well. However, natural resources powerhouse Glencore expects demand for raw materials to remain robust.
Read More »
Free Reports
|
|
